Variant report
Variant | esv2754 |
---|---|
Chromosome Location | chr8:1412460-1412707 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:1407170..1410057-chr8:1410241..1414268,3 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs151232425 | chr8:1412465-1412466 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372831392 | chr8:1412469-1412470 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375913415 | chr8:1412476-1412477 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77534150 | chr8:1412482-1412483 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72507645 | chr8:1412485-1412486 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74354693 | chr8:1412498-1412499 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74728762 | chr8:1412501-1412502 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372124804 | chr8:1412509-1412510 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75032215 | chr8:1412513-1412514 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566553435 | chr8:1412514-1412515 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs77985912 | chr8:1412515-1412516 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11781950 | chr8:1412517-1412518 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11778408 | chr8:1412524-1412525 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73672723 | chr8:1412533-1412534 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78918423 | chr8:1412545-1412546 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538005606 | chr8:1412546-1412547 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558350176 | chr8:1412547-1412548 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138814886 | chr8:1412551-1412552 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75448211 | chr8:1412552-1412553 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs66489805 | chr8:1412557-1412558 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs199653616 | chr8:1412559-1412560 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs72507646 | chr8:1412566-1412567 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73172557 | chr8:1412577-1412578 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76299330 | chr8:1412578-1412579 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553801407 | chr8:1412579-1412580 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78523771 | chr8:1412581-1412582 | ZNF genes & repeats Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77303340 | chr8:1412650-1412651 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370080907 | chr8:1412666-1412667 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149102661 | chr8:1412673-1412674 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200731012 | chr8:1412678-1412679 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs373223782 | chr8:1412687-1412688 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377312090 | chr8:1412688-1412689 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Cancer | 18840272 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Autism | 20531469 | CNVD |
Breast cancer | 20932292 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:1411600-1416000 | Enhancers | Spleen | Spleen |
2 | chr8:1411800-1413000 | Enhancers | Right Ventricle | heart |
3 | chr8:1412000-1412600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr8:1412200-1412600 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
5 | chr8:1412200-1412600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
6 | chr8:1412200-1412600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
7 | chr8:1412200-1412800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr8:1412200-1412800 | Weak transcription | Left Ventricle | heart |
9 | chr8:1412400-1412600 | Flanking Bivalent TSS/Enh | Adipose Nuclei | Adipose |
10 | chr8:1412400-1412600 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
11 | chr8:1412400-1412800 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
12 | chr8:1412400-1413000 | Enhancers | Pancreas | Pancrea |
13 | chr8:1412600-1413000 | Bivalent/Poised TSS | Adipose Nuclei | Adipose |
14 | chr8:1412600-1413600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr8:1412600-1413800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
16 | chr8:1412600-1416400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |